Bajaj Meditrade Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 09-07-2024
- Paid Up Capital ₹ 2.20 M
as on 09-07-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 26.88%
(FY 2022)
- Profit 26.48%
(FY 2022)
- Ebitda -54.03%
(FY 2022)
- Net Worth 11.71%
(FY 2022)
- Total Assets 2.49%
(FY 2022)
About Bajaj Meditrade
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.20 M, as per Ministry of Corporate Affairs (MCA) records.
Kiran Bajaj and Kishan Bajaj serve as directors at the Company.
- CIN/LLPIN
U51397WB2008PTC123389
- Company No.
123389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Feb 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Bajaj Meditrade Private Limited offer?
Bajaj Meditrade Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Common Disease Medicines, Anaemia Medicine, Pharmaceutical Capsules, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Skin Lightening Drugs.
Who are the key members and board of directors at Bajaj Meditrade?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Bajaj  | Director | 29-Feb-2008 | Current |
| Kishan Bajaj | Director | 29-Feb-2008 | Current |
Financial Performance of Bajaj Meditrade.
Bajaj Meditrade Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.88% increase. The company also saw a substantial improvement in profitability, with a 26.48% increase in profit. The company's net worth Soared by an impressive increase of 11.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bajaj Meditrade?
In 2020, Bajaj Meditrade had a promoter holding of 53.55% and a public holding of 46.45%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bajaj Meditrade?
Unlock and access historical data on people associated with Bajaj Meditrade, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bajaj Meditrade, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bajaj Meditrade's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
